Company Filing History:
Years Active: 2020-2024
Title: **Innovations by Angela DeLucia in Biotechnology**
Introduction
Angela DeLucia is an accomplished inventor based in Cambridge, MA, known for her significant contributions to biotechnology. With a total of four patents to her name, DeLucia is making strides in the field of molecular biology, particularly in the development of polymerases and DNA sequencing technologies.
Latest Patents
One of Angela DeLucia's latest patents is related to a **polymerase enzyme from 9°N**, which boasts an improved ability to incorporate reversibly terminating nucleotides. This invention not only pertains to the mutated enzyme but also includes methods of using such enzymes along with kits containing these polymerases.
In addition, she holds a patent for a **DNA sequencing reaction additive**. This invention provides a range of methods, compositions, mixtures, and kits that utilize 5-Chloro-2-methyl-4-isothiazolin-3-one in sequencing reactions. Specifically, it involves sequencing reactions that use deoxynucleoside triphosphates with a cleavable protecting group and a detectable label. Such innovations open up new possibilities for future sequencing technologies, particularly in Sequencing by Synthesis.
Career Highlights
Angela DeLucia has a rich career, having worked with prominent companies in the biotechnology sector. She has served at **Isoplexis Corporation** and **Qiagen Sciences, LLC**, where she developed her skills and contributed to significant projects.
Collaborations
Throughout her career, Angela has collaborated with talented individuals, including Luisa Andruzzi and Ben McNally. These collaborations have allowed her to expand her research and make meaningful advancements in her fields of expertise.
Conclusion
Angela DeLucia is a noteworthy figure in the world of biotechnology, with her patents reflecting her innovative spirit and commitment to advancing DNA sequencing technologies. Her work continues to influence the scientific community and paves the way for future breakthroughs in molecular biology.